|
||
© The Rockefeller University Press,
0021-9525/2000//243 $5.00
The Journal of Cell Biology, Volume 150, Number 1,
, 2000 243-252
Original Article |
Intercellular Adhesion Molecule-5 Induces Dendritic Outgrowth by Homophilic Adhesion
carl.gahmberg{at}helsinki.fi
Intercellular adhesion molecule-5 (ICAM-5) is a dendritically polarized membrane glycoprotein in telencephalic neurons, which shows heterophilic binding to leukocyte β2-integrins. Here, we show that the human ICAM-5 protein interacts in a homophilic manner through the binding of the immunoglobulin domain 1 to domains 4–5. Surface coated ICAM-5-Fc promoted dendritic outgrowth and arborization of ICAM- 5–expressing hippocampal neurons. During dendritogenesis in developing rat brain, ICAM-5 was in monomer form, whereas in mature neurons it migrated as a high molecular weight complex. The findings indicate that its homophilic binding activity was regulated by nonmonomer/monomer transition. Thus, ICAM-5 displays two types of adhesion activity, homophilic binding between neurons and heterophilic binding between neurons and leukocytes.
Key Words: leukocyte integrin adhesion dendrite neuron
© 2000 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
Intercellular adhesion molecule-5 (ICAM-5; telencephalin; Yoshihara et al. 1994; Mizuno et al. 1997) is a cell surface glycoprotein that belongs to the immunoglobulin superfamily and shares 38–55% amino acid identity with the other ICAMs, which play important roles as adhesion molecules in the hematopoietic system (Springer 1994; Gahmberg 1997; Hayflick et al. 1998). Many cell surface proteins involved in cell adhesion belong to the immunoglobulin superfamily. Such proteins contain a variable number of immunoglobulin domains, which are
100 amino acids long and form two β-sheets. Human ICAM-5 consists of nine extracellular immunoglobulin domains with a total of 832 amino acids, a 28-amino acid transmembrane segment, and a 64-amino acid cytoplasmic domain. Like other ICAMs, it binds to the leukocyte integrin CD11a/CD18 (Mizuno et al. 1997; Tian et al. 1997) and it may be an important regulator of the immune response in the central nervous system.
ICAM-5 has several features that make it a candidate for a DenCAM. Firstly, it is localized to cell somata and dendrites of neurons, and neurons expressing ICAM-5 have more extensive dendritic branches than neurons without ICAM-5 (Benson et al. 1998). Secondly, it is expressed only in the telencephalon, the most rostral segment of the brain, and not in the caudal segments (Yoshihara and Mori 1994). Thirdly, the onset of its expression temporally parallels the onset of dendritic elongation and synaptogenesis during the postnatal period. These facts together support the hypothesis that ICAM-5 may provide a brain segment-specific cue for synaptogenesis or dendrite–dendrite interactions in the telencephalon. Indeed, earlier studies have shown that ICAM-5 promotes embryonic hippocampal neurite outgrowth (Tamada et al. 1998) and is involved in hippocampal long-term potentiation (Sakurai et al. 1998). However, the molecular basis has remained poorly understood.
Here, we attempted to address this issue by studying purified recombinant human ICAM-5 proteins, ICAM-5 transfected into a human neural crest derived cell line (Paju), and ICAM-5 in developing rat brain. We found that ICAM-5 induced neurite outgrowth of Paju cells and rat hippocampal neurons through homophilic interaction, and it also promoted the dendritic arborization of hippocampal neurons through homophilic binding. The adhesive domains in ICAM-5 were mapped, and we propose that the homophilic activity of ICAM-5 is regulated by a monomer/nonmonomer transition.
| Materials and Methods |
|---|
|
|
|---|
After methanol fixation, the cells were stained with FITC-conjugated rabbit anti–mouse antiserum (Jackson ImmunoResearch Laboratories). Cells were observed by immunofluorescence microscopy (Olympus Provis 70) at 400x.
Production of Recombinant Proteins
Truncated ICAM-5 extracellular domains were cloned by PCR from human ICAM-5 cDNA, sequenced, and inserted into the pEF-Fc (Tian et al. 1997; Tamada et al. 1998) expression vector. The recombinant proteins were purified from transiently transfected COS-1 (American Type Culture Collection) cells using protein A–Sepharose CL 4B (Amersham Pharmacia Biotech) and their purities checked by Western blotting using HRP-conjugated anti-human Ig (Amersham Pharmacia Biotech). Soluble ICAM-5 immunoglobulin domain 1–9 (D1–9) without Fc was purified from a baculovirus-expression system (Bac-to-bac system; GIBCO BRL).
Flow Cytometry and ELISA
106 Paju-WT and Paju-ICAM-5 cells were first incubated with 100 µg/ml recombinant ICAM-5-Fc, ICAM-1-Fc, and NCAM-Fc proteins, followed by FITC-conjugated anti-human IgG (Dako) at room temperature for 30 min. After washings, samples were analyzed with FACScan and CellQuest software (Becton Dickinson). The mean fluorescent value of Paju-ICAM-5 was subtracted with that of Paju-WT for each recombinant protein. For ELISA, 5 µg/ml recombinant proteins were coated on microtiter plates, blocked with BSA (Sigma-Aldrich), and then incubated first with biotinylated domains 1–2 Fc (D1–2-Fc; Pierce) of ICAM-5, and then with HRP-conjugated streptavidin (Pierce Chemical Co.) at 37°C for 1 h, and the color measured at 492 nm. For mAb blocking assay, 5 µg/ml ICAM-5 D1–9 was coated and preincubated with anti–ICAM-5 mAbs at room temperature for 30 min, followed by the steps mentioned above.
Native PAGE and Western Blotting
Brains of embryonic (embryonic day 19, E19), newborn (postnatal day 1–10, P1-10), and adult rats were homogenized in 10 mM Tris, 1 mM EDTA, 10 mM Chaps, 300 mM NaCl, and 1 mM PMSF. Paju-ICAM-5 cells were treated with 5 µM cytochalasin D (Calbiochem-Novabiochem) or 0.5 mg/ml ICAM-5 D1–2-Fc protein for 8 or 4 h, respectively, and were then lysed with the same buffer. Brain homogenates or cell lysates were run on native PAGE with PhastGel 4-15 (Amersham Pharmacia Biotech) and blotted onto nitrocellulose membranes. ICAM-5 protein was detected by a polyclonal antibody against the cytoplasmic part of mouse ICAM-5 (Tian et al. 1997).
Neurite Outgrowth Assay
0.5 µg of D1–2-Fc or D1–9-Fc of ICAM-5 and ICAM-1-Fc proteins were coated in drops on coverslips in 24-well plates. After blocking, the coverslips with BSA, 104/well Paju-WT and Paju-ICAM-5 cells were seeded and cultured for 30–36 h. For mAb inhibition assay, 50 µg/ml mAb 179B was incubated with Paju-WT and Paju–ICAM-5 cells. Cells were observed under phase-contrast microscope (Olympus Provis 70) at 400x. The length of the neurites was measured as the distance between the soma and the tip of the neurite counted in three random fields.
Hippocampus and cerebellum were dissected from 19-d-old rat embryos and treated with 0.5 mg/ml papain for 10 min (Worthington Biochemical Corp.) in HBSS (GIBCO BRL). After washing in HBSS, neurons suspended in Neurobasal medium (GIBCO BRL), 2% B27 supplement (GIBCO BRL), 25 µM L-glutamic acid (Sigma-Aldrich), and 1% L-glutamine (GIBCO BRL) were seeded at 104/well density in 8-chamber slides (Nunc) coated with laminin (50 µg/ml; Sigma-Aldrich), HB-GAM (Rauvala and Peng 1997; 50 µg/ml), poly-DL-ornithine (100 µg/ml; Sigma-Aldrich), or ICAM-5 recombinant proteins (100 µg/ml). For inhibition assay, 100 µg/ml of each antibody or recombinant protein was added to the culture medium. Neurons were cultured for 48 or 72 h, and were then fixed with 4% paraformaldehyde for 25 min. After permeabilization with 0.2% Triton X-100 for 10 min, the neurons were visualized with the dendritic marker, antimicrotubule associated protein-2 (anti–MAP-2) mAb (Boehringer), the axonal marker antitau mAb (Boehringer), or rabbit anticytoplasmic mouse ICAM-5 antiserum for 1 h at room temperature (Benson et al. 1998), followed by incubation with TRITC-conjugated goat anti–rabbit and FITC-conjugated goat anti–mouse antibodies (Jackson ImmunoResearch Laboratories, Inc.). The proportion of neurite-bearing cells (processes longer than 1 diam of the cell body) was counted in four random fields using a fluorescence microscope (Olympus Provis 70) at 400x.
Statistical Analysis
For all the quantitations, statistical analysis of variance (ANOVA) was used to compare the different groups in each experiment.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
A number of factors are known to be involved in axonal guidance, including diffusible or surface-bound growth-promoting molecules and various adhesion molecules (Jessell 1988), such as cadherins (Takeichi 1991; Tamura et al. 1998), integrins (Hynes 1992), and immunoglobulin superfamily molecules (Sonderegger and Rathjen 1992; Goodman and Shatz 1993). In contrast, only ICAM-5 has been shown to have a restricted expression to soma-dendritic membranes of telencephalic neurons (Yoshihara et al. 1994; Benson et al. 1998). The immunofluorescence studies show that ICAM-5 had a similar distribution as the dendritic marker MAP-2. MAP-2 evidently also stained some axons (Fig. 7 b), probably due to the fact that the neurons at this stage are not absolutely polarized. In contrast, axon staining with antitau showed a different distribution and little overlap was seen in cells grown on ICAM-5. When coated on laminin, a number of tau+ neurites were seen. The stainings indicate that ICAM-5 promotes the expression of dendritic proteins, such as MAP-2, much better than laminin, whereas laminin promotes the expression of axonal proteins such as tau.
Although the function of ICAM-5 as a brain-specific leukocyte-binding protein is well established (Mizuno et al. 1997; Tian et al. 1997), its strong and specific expression in the telencephalon, especially in the cerebrum and hippocampus, indicated that it may possess other functions. Here, we describe that ICAM-5 induces dendritic extension and branching through homophilic adhesion, the effect of which is dramatically different from that of laminin (Höpker et al. 1999) or HG-GAM (Rauvala and Peng 1997), which are known to mainly promote axonal outgrowth, and that this activity can be blocked by mAbs against ICAM-5.
The first indication of homophilic binding was obtained when we observed that ICAM-5 transfected in Paju cells was enriched at the cell–cell contact sites. However, when we made the entire external part of ICAM-5 by recombinant methods, it did not show homophilic binding. This issue was then studied by making truncated shorter constructs of the molecule. We then found that the binding activity was mediated by homophilic binding of the NH2-terminal domain 1 to domains 4–5. Constructs containing domains 1–2 were more efficient in binding than the single first domain. The finding that mAbs reacting with domain 2 did not inhibit binding further indicates that domain 2 is not directly involved in binding. In fact, some antibodies to D2 enhanced binding, which could be due to conformational changes in D1. The reason for the inability of the isolated D1–9 construct to mediate binding could be its strong tendency to form higher aggregates, possibly tetramers in vitro.
When we performed an analysis of the calculated pI values of the ICAM-5 extracellular domains, we found that in all species of cloned ICAM-5, the pI values of domains 1–2 were
11.3, whereas those of domains 4–5 were
4.3, suggesting that the homophilic interaction of D1 with D4–5 could be at least partially mediated by electrostatic interactions between the respective domains. This characteristic of highly oppositely charged domains in ICAM-5 is unique among the ICAMs. This may be the reason that ICAM-1 did not show any homophilic binding. Nor did ICAM-1 bind ICAM-5, which shows that the binding is highly specific.
Earlier studies on neural adhesion molecules have shown that the homophilic binding of the neuronal cell adhesion molecule (NCAM) involves all of the five Ig domains (Ranheim et al. 1996), whereas in the case of L1 and cadherin, only Ig domain 2 in L1 (Zhao and Siu 1995) and domain 1 in cadherin (Tamura et al. 1998) are involved. The complex phenomena of homophilic binding of different cell adhesion molecules must underlie their different functions, not only in adhesion, but also in possible signaling events (Brümmendorf and Rathjen 1996).
Multimerization of cell surface molecules is commonly believed to enhance the binding to their ligands/receptors through an increase in avidity. Such examples are the homodimerization of cadherin (Tamura et al. 1998) and ICAM-1 (Miller et al. 1998), and the heterodimerization of NgCAM and axonin-1 (Kunz et al. 1998). The behavior of ICAM-5 is different from that of the other studied Ig domain-containing adhesion proteins.
We think that the inability of the ICAM-5 high molecular weight form to adhere is due to the fact that the homophilic binding of ICAM-5 requires a deeper accessibility of two opposite polypeptides. Furthermore, the studies with the truncated ICAM-5 molecules show that intramolecular associations may exist. The short constructs, like D1–2, can bind because they have their binding domains accessible, whereas longer constructs, like D1–5, are inactive because of interpolypeptide association between D1 and D4–5.
High local concentrations of ICAM-5 may promote high molecular weight complex formation as seen in Paju cells where the uropods are especially rich in the protein. The nonmonomer state must not, however, be permanent in vivo because when Paju-ICAM-5 cells were incubated with truncated ICAM-5 fusion proteins containing the two NH2-terminal domains, the ICAM-5 molecules cells were brought into monomers. How this phenomenon is regulated in vivo remains unknown. When Paju-ICAM-5 cells were treated with cytochalasin D, ICAM-5 completely switched into monomers. These facts indicate a linkage of ICAM-5 with cytoskeletal proteins, as with other ICAM molecules (Carpén et al. 1992; Heiska et al. 1996). ICAM-5 was previously observed to concentrate in dendritic growth cones and filopodia in hippocampal neurons (Benson et al. 1998). Experiments with cytochalasins to disrupt actin filaments within axonal growth cones have shown that the actin cytoskeleton is necessary for correct pathfinding in vivo (Forscher and Smith 1988; Sheetz et al. 1992; Chien et al. 1993), and for directed neurite outgrowth in vitro (Smith 1988; Sheetz et al. 1992). The binding of adhesion molecules on the surface of cells may mediate changes in the cytoskeletal scaffold, thereby resulting in stabilized adhesion or forward growth (Lin et al. 1994). The dynamic change of adhesiveness between monomers and nonmonomers of ICAM-5, which may be regulated by the cytoskeleton, offers an interesting possibility of regulation of dendritic outgrowth.
Regulation of ICAM-5 binding by nonmonomer/monomer transition could also be a means of influencing leukocyte integrin–ICAM-5 interaction. We have found that CD11a/CD18 binds to the first Ig domain of ICAM-5 (Tian et al. 2000), and some mAbs that blocked the ICAM-5-integrin interaction also blocked the ICAM-5 homophilic binding, so the binding sites for these two activities are partially overlapping.
It has been known that dendritogenesis and synaptogenesis take place during the early postnatal period (Goodman and Shatz 1993; Craig and Banker 1994). Therefore, we studied ICAM-5 during this time in rats where brain development has been extensively studied (Craig and Banker 1994). Interestingly, during the first postnatal week, ICAM-5 mainly existed as monomers, whereas at postnatal days 7–10, it gradually changed into nonmonomers. Whether the nonmonomer form is a tetramer or a complex of ICAM-5 with other proteins is not known. This transition coincides with dendritogenesis in the early postnatal period of the rodent central nervous system. Obviously, it is important that when neurons extend branches of dendrites they also need signals for distinguishing axonal growth cones from dendritic ones so that the correct synapses are formed. At an early stage of dendritogenesis, ICAM-5 monomers could promote dendritic elongation and arborization through homophilic interaction. When neurons become developmentally more mature, ICAM-5 mainly exists as nonmonomers, whereby it does not promote dendrite–dendrite/soma interactions. It is possible that promotion of dendrite–dendrite adhesion by monomeric ICAM-5 does not promote branching, and conversely, that the nonmonomeric form could induce more branching.
| Acknowledgments |
|---|
This study was supported by the Academy of Finland, the Sigrid Jusélius Foundation, and the Finnish Cancer Society.
Submitted: 29 November 1999
Revised: 23 May 2000
Accepted: 25 May 2000
Abbreviations used in this paper: AxCAM, axon-associated cell adhesion molecule; D, immunoglobulin domain; DenCAM, dendrite-associated cell adhesion molecule; E19, embryonic day 19; ICAM, intercellular adhesion molecule; MAP-2, microtubule-associated protein-2; P, postnatal day; WT, wild-type.
| References |
|---|
|
|
|---|
Benson D.L. Yoshihara Y. Mori K. Polarized distribution and cell type-specific localization of telencephalin, an intercellular adhesion molecule, J. Neurosci. Res., 52, 1998, 43–53.[Medline]
Brümmendorf T. Rathjen F.G.. Structure/function relationships of axon-associated adhesion receptors of the immunoglobulin superfamily, Curr. Opin. Neurobiol, 6, 1996, 584–593.[Medline]
Carpén O. Pallai P. Staunton D.E. Springer T.A.. Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and
-actinin, J. Cell Biol, 118, 1992, 1223–1234.
Chien C.B. Rosenthal D.E. Harris W.A. Holt C.E.. Navigational errors made by growth cones without filopodia in the embryonic Xenopus brain, Neuron., 11, 1993, 237–251.[Medline]
Cook G. Tannahill D. Keynes R.. Axon guidance to and from choice points, Curr. Opin. Neurobiol, 8, 1998, 64–72.[Medline]
Craig A.M. Banker G.. Neuronal polarity, Annu. Rev. Neurosci, 17, 1994, 267–310.[Medline]
Forscher P. Smith S.J.. Actions of cytochalasins on the organization of actin filaments and microtubules in a neuronal growth cone, J. Cell Biol, 107, 1988, 1505–1516.
Gahmberg C.G.. Leukocyte adhesionCD11/CD18 integrins and intercellular adhesion molecules, Curr. Opin. Cell Biol, 9, 1997, 643–650.[Medline]
Goodman C.S. Shatz C.J.. Developmental mechanisms that generate precise patterns of neuronal connectivity, Cell., 72, 1993, 77–98.[Medline]
Hayflick J.S. Kilgannon P. Gallatin W.M.. The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions, Immunol. Res., 17, 1998, 313–327.[Medline]
Heiska L. Kantor C. Parr T. Critchley D.R. Vilja P. Gahmberg C.G. Carpén O.. Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to
-actinin, J. Biol. Chem., 271, 1996, 26214–26219.
Höpker V.H. Shewan D. Tessier-Lavigne M. Poo M.M. Holt C.. Growth-cone attraction to netrin-1 is converted to repulsion by laminin-1, Nature., 401, 1999, 69–73.[Medline]
Hynes R.O.. Integrinsversatility, modulation, and signaling in cell adhesion, Cell., 69, 1992, 11–25.[Medline]
Hynes R.O. Lander A.D.. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons, Cell., 68, 1992, 303–322.[Medline]
Jessell T.M.. Adhesion molecules and the hierarchy of neural development, Neuron., 1, 1988, 3–13.[Medline]
Kunz S. Spirig M. Ginsburg C. Buchstaller A. Berger P. Lanz R. Rader C. Vogt L. Kunz B. Sondereger P.. Neurite fasciculation mediated by complexes of axonin-1 and Ng cell adhesion molecule, J. Cell Biol, 143, 1998, 1673–1690.
Lin C.H. Lamoureux P. Buxbaum R.E. Forscher P.. Cytoskeletal reorganization underlying growth cone motility, Curr. Opin. Neurobiol, 4, 1994, 640–647.[Medline]
Miller J. Knorr R. Ferrone M. Houdei R. Carron C.P. Dustin M.L.. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1, J. Exp. Med, 182, 1998, 1231–1241.[Medline]
Mizuno T. Yoshihara Y. Inazawa J. Kagamiyama H. Mori K.. cDNA cloning and chromosomal localization of the human telencephalin and its distinctive interaction with lymphocyte function-associated antigen-1, J. Biol. Chem, 272, 1997, 1156–1163.
Oka S. Mori K. Watanabe Y.. Mammalian telencephalic neurons express a segment-specific membrane glyprotein, telencephalin, Neurosci, 35, 1990, 93–103.[Medline]
Ranheim T.S. Edelman G.M. Cunningham B.A.. Homophilic adhesion mediated by the neural cell adhesion molecule involves multiple immunoglobulin domains, Proc. Natl. Acad. Sci, 93, 1996, 4071–4075.
Rauvala H. Peng H.B.. HB-GAM (heparin-binding growth-associated molecule) and heparin type glycans in the development and plasticity of neuron-target contacts, Progress Neurobiol., 52, 1997, 127–144.[Medline]
Sakurai E. Hashikawa T. Yoshihara Y. Kaneko S. Satoh M. Mori K.. Involvement of dendritic adhesion molecule telencephalin in hippocampal long-term potentiation, Neuroreport., 9, 1998, 881–886.[Medline]
Sheetz M.P. Wayne D.B. Pearlman A.L.. Extension of filopodia by motor-dependent actin assembly, Cell. Motil. Cytoskel., 22, 1992, 160–169.[Medline]
Smith S.J.. Neuronal cytomechanicsthe actin-based motility of growth cones, Science., 242, 1988, 708–715.
Sonderegger P. Rathjen F.G.. Regulation of axonal growth in the vertebrate nervous system by interactions between glycoproteins belonging to two subgroups of the immunoglobulin superfamily, J. Cell Biol, 119, 1992, 1387–1394.
Springer T.A.. Traffic signals for lymphocyte recirculation and leukocyte emigrationthe multistep paradigm, Cell., 76, 1994, 301–314.[Medline]
Takeichi M.. Cadherin cell adhesion receptors as a morphogenetic regulator, Science., 251, 1991, 1451–1455.
Tamada A. Yoshihara Y. Mori K.. Dendrite-associated cell adhesion molecule, telencephalin, promotes neurite outgrowth in mouse embryo, Neurosci. Lett, 240, 1998, 163–166.[Medline]
Tamura K. Shan W.S. Hendrickson W.A. Colman D.R. Shapiro L.. Structure–function analysis of cell adhesion by neural (N–) cadherin, Neuron., 20, 1998, 1153–1163.[Medline]
Tessier-Lavigne M. Goodman C.S.. The molecular biology of axon guidance, Science., 274, 1996, 1123–1133.
Tian L. Yoshihara Y. Mizuno T. Mori K. Gahmberg C.G.. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin, J. Immunol, 158, 1997, 928–936.[Abstract]
Tian L. Kilgannon P. Yoshihara Y. Mori K. Gallatin W.M. Carpén O. Gahmberg C.G.. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18, Eur. J. Immunol, 30, 2000, 810–818.[Medline]
Walsh F.S. Doherty P.. Neural cell adhesion molecules of the immunoglobulin superfamilyrole in axon growth and guidance, Annu. Rev. Cell Dev. Biol, 13, 1997, 425–456.[Medline]
Yoshihara Y. Mori K.. Telencephalina neuronal area code molecule?, Neurosci. Res, 21, 1994, 119–124.[Medline]
Yoshihara Y. Oka S. Nemoto Y. Watanabe Y. Nagata S. Kagamiyama H. Mori K.. An ICAM-related neuronal glycoprotein, telencephalin, with brain segment-specific expression, Neuron., 12, 1994, 541–553.[Medline]
Zhang K.Z. Westberg J.A. Hölttä E. Andersson L.C.. BCL2 regulates neural differentiation, Proc. Natl. Acad. Sci, 93, 1996, 4504–4508.
Zhao X. Siu C.H.. Colocalization of the homophilic binding site and the neuritogenic activity of the cell adhesion molecule L1 to its second Ig-like domain, J. Biol. Chem, 270, 1995, 29413–29421.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|